Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBIT Margin (2020 - 2025)

LifeStance Health (LFST) has disclosed EBIT Margin for 6 consecutive years, with 0.91% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 123.0% to 0.91% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.18%, a 271.0% increase, with the full-year FY2025 number at 0.18%, up 271.0% from a year prior.
  • EBIT Margin was 0.91% for Q4 2025 at LifeStance Health, down from 2.04% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 2.04% in Q3 2025 to a low of 71.72% in Q3 2021.
  • A 5-year average of 17.29% and a median of 12.5% in 2023 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: crashed -7435bps in 2021, then soared 5386bps in 2022.
  • LifeStance Health's EBIT Margin stood at 63.97% in 2021, then surged by 69bps to 20.06% in 2022, then soared by 43bps to 11.5% in 2023, then soared by 103bps to 0.33% in 2024, then plummeted by -379bps to 0.91% in 2025.
  • Per Business Quant, the three most recent readings for LFST's EBIT Margin are 0.91% (Q4 2025), 2.04% (Q3 2025), and 0.85% (Q2 2025).